Carlsmed (CARL) Net Margin (2024 - 2026)

Carlsmed (CARL) reported Net Margin of 53.96% for Q1 2026, up 800.0% on a YoY basis from 6.0% in Q1 2025, and up 4.99% quarter-over-quarter from 56.8% in Q4 2025.

Carlsmed (CARL) Net Margin (2024 - 2026) Analysis & Trends

Carlsmed has reported Net Margin for 3 years, with the latest figure at 53.96% in Q1 2026.

  • For the quarter ending Q1 2026, Net Margin rose 800.0% year-over-year to 53.96%; the trailing twelve-month figure through Mar 2026 stood at 57.76% (up 2193.0% YoY), and the FY2025 full-year result was 59.82%, up 3165.0% from the prior year.
  • Net Margin for Q1 2026 stood at 53.96%, up from 56.8% in the prior quarter.
  • The five-year high for Net Margin was 50.17% in Q4 2024, with the low at 127.54% in Q3 2024.
  • Historically, Net Margin has averaged 71.86% across 3 years, with a median of 59.38% in 2025.
  • The largest YoY upside for Net Margin was 6233 bps in 2025 against a maximum downside of 663 bps in 2025.
  • Carlsmed's Net Margin stood at 50.17% in 2024, then slipped by 13 bps to 56.8% in 2025, then climbed by 5 bps to 53.96% in 2026.
  • The last three Net Margin figures came in at 53.96% (Q1 2026), 56.8% (Q4 2025), and 65.21% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Veeva Systems 24.83 Bn 17.52 Bn 662.02 Mn 29.55%
2 BrightSpring Health Services 13.57 Bn 12.69 Bn 482.22 Mn 2.06%
3 Healthequity 7.20 Bn 6.93 Bn 256.31 Mn 19.57%
4 Hinge Health 5.42 Bn 5.11 Bn 154.23 Mn 18.66%
5 10x Genomics 4.46 Bn 3.92 Bn 106.18 Mn -8.93%
6 Doximity 3.81 Bn 3.06 Bn 125.97 Mn 13.15%
7 Waystar Holding 3.52 Bn 3.36 Bn 268.04 Mn 13.80%
8 Privia Health 2.94 Bn 2.57 Bn 595.71 Mn 0.61%
9 Omnicell 1.76 Bn 1.59 Bn 140.36 Mn 3.68%
10 Carlsmed 265.54 Mn 168.34 Mn 12.43 Mn -53.96%

Historic Data

Download Data
DateValue
Mar 31, 2026 -53.96%
Dec 31, 2025 -56.80%
Sep 30, 2025 -65.21%
Jun 30, 2025 -56.00%
Mar 31, 2025 -61.96%
Dec 31, 2024 -50.17%
Sep 30, 2024 -127.54%
Jun 30, 2024 -103.22%